Stock Analysis
- India
- /
- Healthcare Services
- /
- NSEI:HCG
Indian Exchange Growth Companies With High Insider Ownership June 2024
Reviewed by Simply Wall St
The Indian stock market has shown remarkable growth, climbing 2.7% in the last week and an impressive 45% over the past year, with earnings projected to grow by 16% annually. In this buoyant environment, stocks with high insider ownership can be particularly appealing as they often indicate a strong alignment between company management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In India
Name | Insider Ownership | Earnings Growth |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 28.9% |
Pitti Engineering (BSE:513519) | 33.6% | 28.0% |
Rajratan Global Wire (BSE:517522) | 19.8% | 33.5% |
Dixon Technologies (India) (NSEI:DIXON) | 24.9% | 33.5% |
Happiest Minds Technologies (NSEI:HAPPSTMNDS) | 37.8% | 22.9% |
Jupiter Wagons (NSEI:JWL) | 11.1% | 27.2% |
Paisalo Digital (BSE:532900) | 16.3% | 23.8% |
JNK India (NSEI:JNKINDIA) | 23.8% | 31.8% |
Apollo Hospitals Enterprise (NSEI:APOLLOHOSP) | 10.4% | 33.1% |
Pricol (NSEI:PRICOLLTD) | 25.5% | 26.9% |
Underneath we present a selection of stocks filtered out by our screen.
HealthCare Global Enterprises (NSEI:HCG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: HealthCare Global Enterprises Limited operates in the healthcare sector, specializing in cancer and fertility services, with a market capitalization of approximately ₹54.50 billion.
Operations: The company generates revenue primarily through setting up and managing hospitals and medical diagnostic services, totaling ₹18.59 billion.
Insider Ownership: 13.8%
Revenue Growth Forecast: 11.8% p.a.
HealthCare Global Enterprises, a key player in the Indian healthcare sector, has demonstrated robust financial performance with a significant increase in quarterly sales and net income as of Q4 2024. Despite high insider ownership, the founder has no plans to alter his stake amidst potential acquisition interest from major investors like Temasek. The company's earnings are expected to grow substantially over the next three years, outpacing average market growth. However, its ability to cover interest payments is weak, posing a financial risk.
- Navigate through the intricacies of HealthCare Global Enterprises with our comprehensive analyst estimates report here.
- Upon reviewing our latest valuation report, HealthCare Global Enterprises' share price might be too pessimistic.
Nazara Technologies (NSEI:NAZARA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nazara Technologies Limited is a company that operates a gaming and sports media platform both in India and internationally, with a market capitalization of approximately ₹66.01 billion.
Operations: The company generates revenue primarily through three segments: Gaming (₹4.06 billion), E-Sports (₹6.32 billion), and AD Tech Business (₹1.04 billion).
Insider Ownership: 22.5%
Revenue Growth Forecast: 16% p.a.
Nazara Technologies, an Indian gaming and sports media company, has seen earnings grow by 72.2% over the past year with forecasts suggesting a further 23.37% annual increase. Despite high insider ownership, the company's share price remains volatile. Recent strategic moves include bidding for Smaaash Entertainment to expand its entertainment offerings, supported by a significant fund allocated for mergers and acquisitions aimed at boosting its game development division’s revenue to ₹10 billion by FY25.
- Click here to discover the nuances of Nazara Technologies with our detailed analytical future growth report.
- Insights from our recent valuation report point to the potential overvaluation of Nazara Technologies shares in the market.
Praj Industries (NSEI:PRAJIND)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Praj Industries Limited specializes in bio-based technologies and engineering solutions globally, with a market capitalization of approximately ₹128.63 billion.
Operations: The company generates ₹34.66 billion in revenue from its Process and Project Engineering segment.
Insider Ownership: 29.0%
Revenue Growth Forecast: 16.6% p.a.
Praj Industries, a key Indian company in the bio-energy sector, has demonstrated robust earnings growth of 34.6% annually over the past five years. Forecasted to grow earnings by 19.82% per year and revenue by 16.6% per year, it outpaces the broader Indian market's growth rates. However, its dividend coverage is weak, with recent dividends not well supported by cash flows despite a proposed increase to INR 6 per share this fiscal year. Insider activity has been mixed with no substantial buying reported recently.
- Take a closer look at Praj Industries' potential here in our earnings growth report.
- In light of our recent valuation report, it seems possible that Praj Industries is trading beyond its estimated value.
Key Takeaways
- Get an in-depth perspective on all 82 Fast Growing Indian Companies With High Insider Ownership by using our screener here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if HealthCare Global Enterprises might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NSEI:HCG
HealthCare Global Enterprises
Provides medical and healthcare services focusing on cancer and fertility in India and internationally.